Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.
Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation.
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.
Physiopathological Roles of p2x Receptors in the Central Nervous System.
Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
Durable pharmacological responses from the peptide drug ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.
ATX-MS-1467, An Immunotolerizing Agent, Halts Disease Progression and Reduces CNS Inflammation in Rodent Models of Multiple Sclerosis (P1.216)
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Cluster-tic syndrome as the initial manifestation of multiple sclerosis.
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
Substance Name: Amiloride
Food and Drug Administration Approval Letter for Alemtuzumab
The history of the oxazaphosphorine cytostatics.
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.
Stress signaling etches heritable marks on chromatin.
European Congress of Immunology 2012
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
Peripheral and Central Nervous System Drugs Advisory Committee Meeting: Alemtuzumab (BLA 103948\5139) Background Package

Pages